Beijing Aosaikang Pharmaceutical Valuation
Is 2755 undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Unter dem Marktwert
Deutlich unter dem Marktwert
Price-To-Sales gegen Gleichaltrige
Price-To-Sales gegen Industrie
PM vs. Fair Ratio
Analysten-Prognose
Share Price vs Fair Value
What is the Fair Price of 2755 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Unter dem Marktwert: Unzureichende Daten zur Berechnung des beizulegenden Zeitwerts von 002755 für die Bewertungsanalyse.
Deutlich unter dem Marktwert: Unzureichende Daten zur Berechnung des beizulegenden Zeitwerts von 002755 für die Bewertungsanalyse.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 2755?
Other financial metrics that can be useful for relative valuation.
What is 2755's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | CN¥9.49b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 5.3x |
Enterprise Value/EBITDA | -22.5x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does 2755's PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 6.3x | ||
000813 Dezhan Healthcare | 13.1x | n/a | CN¥6.4b |
002793 Luoxin Pharmaceuticals Group Stock | 3x | n/a | CN¥4.9b |
002626 Xiamen Kingdomway Group | 3x | n/a | CN¥9.1b |
300255 Hebei Changshan Biochemical Pharmaceutical | 6.2x | n/a | CN¥10.5b |
002755 Beijing Aosaikang Pharmaceutical | 6.4x | n/a | CN¥9.5b |
Price-To-Sales gegen Gleichaltrige: 002755 ist auf der Grundlage des Price-To-Sales Verhältnisses (5.4x) im Vergleich zum Durchschnitt der Vergleichsgruppe (5.1x) teuer.
Price to Earnings Ratio vs Industry
How does 2755's PE Ratio compare vs other companies in the CN Pharmaceuticals Industry?
Price-To-Sales gegen Industrie: 002755 ist teuer, wenn man sein Price-To-Sales Verhältnis (6.4x) mit dem CN Pharmaceuticals Branchendurchschnitt (3.9x) vergleicht.
Price to Sales Ratio vs Fair Ratio
What is 2755's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 6.4x |
Fair PS Ratio | n/a |
PM vs. Fair Ratio: Unzureichende Daten zur Berechnung der Price-To-Sales Fair Ratio von 002755 für die Bewertungsanalyse.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analysten-Prognose: Unzureichende Daten für eine Preisprognose.